the world health Organization (WHO) has stopped a large and global trials with malariamidlet as hydroxychloroquine as a treatment for coronaviruses.
It happens, according to results from a number of other trials have shown no beneficial effect. It writes the news agency Reuters.
The global attempts have been with the participation of several countries.
According to Reuters, the decision to drop the global experiment have been announced at a press conference Wednesday.
at Home, it has also been examined as hydroxychloroquine may help in the fight against coronavirus.
At the beginning of June, the Danish medicines agency on the new coronaforsøg with the agent, who is really developed for use against malaria.
It came to pass, after the Danish medicines agency in late may stopped the Danish trials.
the Reason that the agency chose to douse the Danish trials, there was an article in the british journal The Lancet, which indicated that there were side effects of the medicine.
A part of the results in the article, however, was subsequently withdrawn, as there were doubts about the quality of the test results from the trials with the remedy. There was among other things pointed to an excess mortality.
Because the results in the article were pulled back, felt the Danish medicines agency that it was right to give the green light to try again.
- It is important that we have generated solid knowledge from clinical trials on medication for the Covid-19.
- that is Why it is good that we can once again give the green light for the tests can be resumed, among other things, because there are raised serious doubts about the information in the Lancet study, said the Danish medicines agency director Thomas Senderovitz, in a press release in the beginning of June.
In Denmark has been given the green light to experiment with as hydroxychloroquine against coronavirus for a total of four hospitals.
The case of Gentofte Hospital, copenhagen university hospital, Hvidovre Hospital and Odense university Hospital.